- Home
- AAT vs AMLX Comparison
AAT vs AMLX Comparison
Compare AAT & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAT | AMLX |
|---|---|---|
| Founded | 1967 | 2014 |
| Country | United States | United States |
| Employees | 208 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AAT | AMLX |
|---|---|---|
| Price | $18.82 | $14.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $20.00 | $19.56 |
| AVG Volume (30 Days) | 362.1K | ★ 820.0K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 7.21% | N/A |
| EPS Growth | N/A | ★ 65.46 |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $436,204,000.00 | $380,786,000.00 |
| Revenue This Year | $4.38 | N/A |
| Revenue Next Year | $0.20 | N/A |
| P/E Ratio | $20.52 | ★ N/A |
| Revenue Growth | N/A | ★ 1612.94 |
| 52 Week Low | $16.69 | $3.11 |
| 52 Week High | $21.40 | $17.49 |
Technical Indicators
Market Signals| Indicator | AAT | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 43.15 | 48.38 |
| Support Level | $18.61 | $13.28 |
| Resistance Level | $19.41 | $15.41 |
| Average True Range (ATR) | 0.49 | 0.96 |
| MACD | -0.12 | -0.05 |
| Stochastic Oscillator | 12.21 | 30.21 |
Price Performance
Historical ComparisonAbout AAT American Assets Trust Inc.
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.